KZIA
Kazia Therapeutics Limited ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.49
-0.52 ▼ -6.49%
🌙 3월 13일 7:18 PM ET (한국 3/14 08:18)
$7.39
-0.10 ▼ -1.33%
| Index | - | P/E | - | EPS (ttm) | -12.31 | Insider Own | - | Shs Outstand | 0.00B | Perf Week | -9.21% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 100% | Insider Trans | - | Shs Float | 0.00B | Perf Month | 42.4% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | 0 | Inst Own | - | Short Float | 4.21% | Perf Quarter | -41.48% |
| Income | -0.01B | P/S | 416.94 | EPS this Y | 99.43% | Inst Trans | 35.47% | Short Ratio | 0.3 | Perf Half Y | -8.1% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -145.87% | Short Interest | 0.07M | Perf YTD | 8.71% |
| Book/sh | -3.36 | P/C | 4.39 | EPS past 3/5Y | 43.68% 25.92% | ROE | -3028.18% | 52W High | -56.95% ($17.40) | Perf Year | 56.04% |
| Cash/sh | 1.71 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 161.89% ($2.86) | Perf 3Y | -84.71% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 63.05% | Gross Margin | - | Volatility(W/M) | 11.93% 14.34% | Perf 5Y | -98.64% |
| Dividend TTM | - | EV/Sales | 330.61 | Sales Y/Y TTM | -98.25% | Oper. Margin | -39043.54% | ATR (14) | 1 | Perf 10Y | -98.17% |
| Dividend Ex-Date | - | Quick Ratio | 0.35 | EPS Q/Q | 80.37% | Profit Margin | -50335.51% | RSI (14) | 49.42 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.35 | Sales Q/Q | -98.25% | SMA20 | -0.53% ($7.53) | Beta | 1.61 | Target Price | $19 |
| Payout | - | Debt/Eq | - | Earnings | 2026/03/03 | SMA50 | 9.42% ($6.85) | Rel Volume | 0.39 | Prev Close | $8.01 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -4.12% ($7.81) | Avg Volume(3M) | 0.23M | Price | $7.49 |
| IPO | 1999/1/6 | Option/Short | Yes/Yes | Trades | 581 | Volume | 87,774 | Change | -6.49% |
뉴스 로딩 중...